| Bioactivity | Val-Cit-PAB-DEA-Dxd (compound 81) is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule Dxd (DNA topoisomerase I inhibitor). Val-Cit-PAB-DEA-Dxd can be used for ADC synthesis[1]. |
| CAS | 2964543-53-9 |
| Formula | C50H61FN10O12 |
| Molar Mass | 1013.08 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dechun Wu, et al. Pegylated antibody hydroxyl-bearing drug conjugate. Patent WO2023151679A1. |
Val-Cit-PAB-DEA-Dxd
CAS: 2964543-53-9 F: C50H61FN10O12 W: 1013.08
Val-Cit-PAB-DEA-Dxd (compound 81) is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecul
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.